Erythropoietin (EPO) and TB-500 Interaction
Erythropoietin (EPO) and TB-500 have a compatible interaction with 90% confidence. Different mechanisms; no known interactions. These compounds primarily affect different organ systems.
Compound Profiles
Erythropoietin (EPO)
EPO | Red Blood Cell Stimulating Hormone
EPO binds to erythropoietin receptors (EPOR) on erythroid progenitor cells in bone marrow, activating three interconnected signaling pathways: JAK2/STAT5, PI3K/AKT, and RAS/MAPK. This promotes survival of red blood cell precursors by protecting them from apoptosis, accelerates proliferation and differentiation of erythroid cells, and increases hemoglobin production.
View full profileTB-500
Synthetic Fragment (17-23) of Thymosin Beta-4
Acts as principal actin-sequestering protein, regulating cell migration, promoting angiogenesis, reducing inflammation, and activating stem cell differentiation for comprehensive regenerative effects..
View full profileCombined Organ Load
Shared Safety Flags
Frequently Asked Questions
Can I take Erythropoietin (EPO) with TB-500?
Yes, Erythropoietin (EPO) and TB-500 can generally be taken together. Different mechanisms; no known interactions.
Is Erythropoietin (EPO) and TB-500 safe together?
Based on documented research, this combination is considered compatible. However, shared safety flags include: carcinogenic risk. Monitor accordingly.
What are the interactions between Erythropoietin (EPO) and TB-500?
Different mechanisms; no known interactions. This assessment has 90% confidence and is based on documented research data.
How should I time Erythropoietin (EPO) and TB-500?
Erythropoietin (EPO) has a half-life of 4-12 hours (IV), ~25 hours (SubQ) and TB-500 has a half-life of ~2 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.
This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.